Tirzepatide, a novel medication, is creating significant interest in the scientific community as a potential treatment for both managing blood sugar and reducing body fat. This unique drug works by targeting two distinct receptors, GLP-1 and GIP, leading to enhanced glycemic management and significant slimming in research studies . While preliminar